Common causes of high blood pressure span a wide range of lifestyle factors, physiological processes, underlying medical conditions, and medications — and understanding them is fundamental to both prevention and effective treatment of the most prevalent modifiable cardiovascular risk factor in the world. Hypertension affects nearly half of all US adults and more than one billion people globally, and while it develops through diverse mechanisms in different individuals, the causes can be organized into two broad categories: primary (essential) hypertension, which has no single identifiable cause and accounts for 90–95% of all cases, and secondary hypertension, which results from a specific underlying condition or drug and accounts for 5–10% of cases. Identifying which causes are contributing in a given individual is the first step toward targeted, effective management.
Why Most Hypertension Has No Single Cause
Primary or essential hypertension — the form affecting the vast majority of people with high blood pressure — is not caused by a single pathological event but rather by the cumulative interaction of multiple genetic predispositions and environmental and behavioral exposures over years. Genetic factors account for an estimated 35–65% of blood pressure variability in population studies, reflecting the contribution of multiple common genetic variants — each of individually small effect — that influence kidney sodium handling, vascular tone regulation, aldosterone signaling, sympathetic nervous system activity, and large artery stiffness. No single gene determines most people’s blood pressure, but the cumulative genetic background creates different levels of susceptibility to the environmental and lifestyle factors that are the other major drivers of primary hypertension. Understanding that most hypertension is multifactorial is clinically important because addressing multiple contributing factors simultaneously — dietary sodium, weight, physical activity, alcohol, stress — produces additive blood pressure reductions that can collectively achieve improvements comparable to a single antihypertensive medication.
Excess Dietary Sodium
Excess dietary sodium is the single most extensively studied modifiable cause of high blood pressure. The primary mechanism is renal sodium retention: when dietary sodium intake exceeds the kidney’s capacity to promptly excrete the excess, plasma volume expands, increasing cardiac output and blood pressure. Elevated sodium also has direct effects on vascular smooth muscle and endothelial function that promote vasoconstriction and arterial stiffness. The average dietary sodium intake in the United States is approximately 3,400 mg per day — nearly 50% above the recommended maximum of 2,300 mg/day for the general population, and more than double the 1,500 mg/day recommended for adults with hypertension, heart disease, or kidney disease. The DASH-Sodium trial demonstrated that reducing sodium from approximately 3,300 mg/day to 1,500 mg/day reduced systolic blood pressure by 7.1 mmHg in healthy adults and by 11.5 mmHg in those with hypertension. The degree of blood pressure response to sodium reduction varies substantially between individuals, reflecting differences in salt sensitivity — a trait more pronounced in older adults, in adults with established hypertension, in Black adults, and in individuals with obesity or chronic kidney disease.
Obesity and Overweight
Obesity is one of the most powerful modifiable common causes of high blood pressure, with each 10 kg of excess body weight associated with a systolic blood pressure increase of approximately 3–4 mmHg. Among adults with hypertension, obesity is present in more than 70% of cases. The mechanisms by which excess adiposity raises blood pressure include insulin resistance driving hyperinsulinemia, which stimulates renal sodium reabsorption and activates the sympathetic nervous system; visceral adipose tissue producing renin, angiotensinogen, and inflammatory cytokines that activate the RAAS; and the hypoxic adipose tissue driving further sympathetic and RAAS upregulation. A reduction of 5–10 kg of body weight typically reduces systolic blood pressure by 5–10 mmHg in hypertensive adults — an effect comparable to a single antihypertensive medication.
Physical Inactivity
Physical inactivity is an independent cause of high blood pressure, with sedentary adults showing 30–50% higher rates of hypertension development than physically active adults in longitudinal studies. The mechanisms include elevated resting sympathetic nervous system tone and the close association between physical inactivity and obesity, which independently elevates blood pressure. Regular aerobic exercise improves endothelial function, promotes peripheral vasodilation through enhanced nitric oxide production, reduces resting sympathetic tone, and has direct beneficial effects on kidney function and RAAS activity. Meta-analyses of randomized trials demonstrate that regular aerobic exercise reduces resting systolic blood pressure by approximately 5–7 mmHg in adults with hypertension — an effect of similar magnitude to monotherapy with a single antihypertensive agent in mild hypertension.
Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is one of the most important and frequently underrecognized common causes of high blood pressure, present in approximately 50% of adults with treatment-resistant hypertension. Each apnea event — a temporary cessation of breathing from upper airway obstruction — produces a brief period of oxygen desaturation that triggers an acute surge in sympathetic nervous system activity, causing spikes in heart rate and blood pressure. With dozens to hundreds of apnea events per night, these repetitive sympathetic surges maintain chronically elevated catecholamine levels and increase the sympathetic set-point for blood pressure regulation not only during sleep but throughout the following day. OSA also produces elevated levels of angiotensin II, aldosterone, and inflammatory cytokines that independently promote hypertension through volume expansion and direct vascular effects.
Excessive Alcohol Consumption
Heavy alcohol consumption is a well-established common cause of high blood pressure, with a dose-dependent relationship between alcohol intake and blood pressure level in adults who drink more than approximately two drinks per day. The mechanisms include direct stimulation of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis — producing elevated catecholamine and cortisol levels that increase heart rate and peripheral vascular resistance — as well as interference with the vascular endothelium’s ability to produce nitric oxide. Heavy drinkers may also experience acute blood pressure surges during alcohol withdrawal, reflecting rebound hyperactivity of the sympathetic nervous system following suppression during intoxication. Meta-analyses of randomized trials show that reducing alcohol from heavy drinking levels to moderate drinking (one to two drinks per day or less) reduces systolic blood pressure by approximately 4–6 mmHg.
Chronic Stress, Sleep Deprivation, and Sympathetic Activation
Chronic psychological stress contributes to hypertension through sustained activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Workplace stress, financial stress, relationship conflict, and caregiver burden have all been associated with elevated blood pressure in epidemiological studies. Elevated cortisol promotes sodium retention and vascular inflammation; elevated norepinephrine increases heart rate, cardiac output, and peripheral vascular resistance. Sleep deprivation — defined as less than six hours per night — is also an independent contributor, associated with higher blood pressure, increased sympathetic tone, elevated cortisol, and greater 24-hour blood pressure burden in both observational studies and controlled sleep restriction experiments.
Age, Family History, and Genetic Factors
Age is one of the strongest non-modifiable risk factors for hypertension, with blood pressure rising progressively across adulthood as large elastic arteries stiffen, renal sodium-excretion capacity declines, and RAAS regulation becomes less efficient. The Framingham Heart Study found that approximately 90% of adults who have normal blood pressure at age 55 will eventually develop hypertension if they live to average life expectancy — illustrating that hypertension is nearly inevitable with sufficient longevity for most people. A family history of hypertension substantially increases risk: having one hypertensive parent approximately doubles lifetime hypertension risk; having two hypertensive parents increases it three to four times. The genetic contribution reflects multiple small-effect variants affecting renal sodium handling, vascular reactivity, and aldosterone signaling — a polygenic architecture rather than a simple Mendelian pattern in most individuals. Rare monogenic exceptions include Liddle syndrome (ENaC gain-of-function mutations causing early-onset severe hypertension) and glucocorticoid-remediable aldosteronism, both of which present with specific biochemical and clinical features requiring specialized evaluation and treatment.
Low Dietary Potassium and Its Role in Blood Pressure
While excess sodium intake is the most studied dietary contributor to hypertension, inadequate dietary potassium plays an equally important and often underappreciated role in blood pressure regulation. Potassium promotes sodium excretion through the kidney by directly inhibiting sodium-potassium exchanger activity in the distal nephron, reducing the amount of sodium reabsorbed in exchange for potassium. When potassium intake is low — as is common in Western diets emphasizing processed foods low in fruits and vegetables — this natriuretic mechanism is less active, predisposing to sodium retention and elevated blood pressure. Population studies consistently find that higher dietary potassium intake is associated with lower blood pressure and lower stroke risk, independent of sodium intake. Increasing dietary potassium through consumption of fruits, vegetables, legumes, nuts, and dairy products — the dietary pattern characteristic of the DASH (Dietary Approaches to Stop Hypertension) diet — has been shown in clinical trials to reduce systolic blood pressure by approximately 3–4 mmHg in hypertensive adults. The combination of sodium restriction and potassium augmentation — two fundamental principles of the DASH diet — produces additive blood pressure reductions that exceed either intervention alone.
Secondary Causes of High Blood Pressure
Secondary hypertension accounts for approximately 5–10% of all hypertension cases but represents a critically important category because treating the underlying cause can achieve blood pressure control that medications directed at the blood pressure itself cannot. The most common secondary cause is primary hyperaldosteronism: autonomous overproduction of aldosterone from one or both adrenal glands (an aldosterone-producing adenoma or bilateral adrenal hyperplasia), which causes sodium retention, potassium wasting, and volume-dependent hypertension. Primary hyperaldosteronism may affect 5–10% of all hypertensive adults and is particularly prevalent among those with treatment-resistant hypertension. The diagnostic screen is the aldosterone-to-renin ratio (ARR).
Renovascular hypertension — caused by narrowing of one or both renal arteries — is the second most important secondary cause. In older adults the narrowing is usually atherosclerotic; in younger women, fibromuscular dysplasia (FMD) is the most common cause. Both produce hypertension through reduced kidney perfusion activating the RAAS. Clues include hypertension developing before age 30, sudden worsening of previously controlled hypertension, an abdominal bruit, and an acute rise in creatinine when an ACE inhibitor or ARB is initiated. Chronic kidney disease, pheochromocytoma (a catecholamine-secreting adrenal or extra-adrenal tumor causing episodic or sustained hypertension), thyroid disease, and coarctation of the aorta complete the major secondary causes.
Medications That Raise Blood Pressure
Medication-induced hypertension is an underrecognized and highly treatable common cause of high blood pressure. Non-steroidal anti-inflammatory drugs (NSAIDs) — including ibuprofen, naproxen, and celecoxib — raise blood pressure by inhibiting renal prostaglandins that normally promote natriuresis and by blunting the effects of most antihypertensive drug classes. Estrogen-containing oral contraceptives raise blood pressure in approximately 5% of users through aldosterone-like mechanisms, with effects that resolve on discontinuation. Decongestants containing pseudoephedrine or phenylephrine cause acute sympathomimetic vasoconstriction. Immunosuppressant medications including cyclosporine and tacrolimus, systemic corticosteroids, stimulant medications, serotonin-norepinephrine reuptake inhibitors at higher doses, and cocaine are additional pharmacological causes that are often overlooked when evaluating common causes of high blood pressure.
When to Suspect a Secondary Cause
Several clinical features should prompt evaluation for a secondary cause. Young age at onset — particularly hypertension before age 30 — is a strong signal. Hypertension resistant to three or more antihypertensive agents at optimal doses warrants systematic secondary evaluation. Sudden onset or rapid worsening of previously stable hypertension suggests an acute secondary process. Specific clinical clues — hypokalemia suggesting hyperaldosteronism, episodic headache-palpitations-diaphoresis suggesting pheochromocytoma, features of thyroid disease, differences in blood pressure between arms suggesting coarctation — should direct investigation. Understanding the common causes of high blood pressure enables both targeted prevention in those at risk and appropriate investigation in those in whom secondary causes may be driving the elevation. Additional information is available in our guides on what is high blood pressure, normal blood pressure by age, and why high blood pressure is called a silent condition. Comprehensive resources on hypertension causes and management are available from the American Heart Association, the CDC, and the National Heart, Lung, and Blood Institute.
The Role of Nitric Oxide Deficiency in Hypertension
A final common pathway connecting many of the common causes of high blood pressure is reduced bioavailability of nitric oxide (NO) — the gasotransmitter produced by vascular endothelial cells that is the principal regulator of arterial vasodilation and the primary mechanism by which the endothelium maintains low peripheral vascular resistance. Nitric oxide is produced by endothelial nitric oxide synthase (eNOS) from its substrate L-arginine, and it diffuses into adjacent vascular smooth muscle cells where it activates guanylate cyclase, increasing cyclic GMP and promoting relaxation and vasodilation. When NO bioavailability is reduced — through reduced eNOS activity, increased NO degradation by reactive oxygen species, or reduced L-arginine substrate availability — the balance of vascular tone shifts toward vasoconstriction and elevated peripheral resistance, driving blood pressure higher.
The connection between nitric oxide and the common causes of hypertension is mechanistically direct: sodium overload increases oxidative stress that degrades NO before it can act; obesity and insulin resistance reduce eNOS activity through hyperinsulinemia and the inflammatory adipokines produced by visceral fat; OSA-induced intermittent hypoxia generates reactive oxygen species that inactivate NO; alcohol reduces eNOS expression and promotes vascular inflammation; and chronic psychological stress activates asymmetric dimethylarginine (ADMA) production — an endogenous inhibitor of eNOS. The high fructose content of sugar-sweetened beverages has been shown to increase xanthine oxidase activity and uric acid production, which further degrades NO bioavailability through oxidative mechanisms. This convergence of multiple common causes of high blood pressure onto the shared final pathway of endothelial NO deficiency explains why endothelial dysfunction — measurable by flow-mediated dilation or other non-invasive tests — is one of the earliest detectable vascular abnormalities in hypertension, appearing even before blood pressure is consistently elevated by clinical measurement.
Racial and Ethnic Disparities in the Causes of Hypertension
The prevalence, mechanisms, and clinical characteristics of hypertension differ substantially across racial and ethnic groups, and understanding these differences is important for both population-level prevention and individual clinical management. Black adults in the United States have the highest prevalence of hypertension of any major racial or ethnic group — approximately 56% compared to 48% for white adults — develop hypertension earlier in life, have more severe blood pressure elevation, and experience dramatically worse cardiovascular and renal outcomes from hypertension than white adults. These disparities reflect the intersection of multiple biological, environmental, and structural factors. Biologically, Black adults show higher degrees of salt sensitivity (greater blood pressure response to sodium loading and restriction), lower baseline renin and renin activity, higher aldosterone levels relative to renin — a physiological profile suggesting primary volume expansion as a major blood pressure mechanism — and greater baseline vascular stiffness than white adults at comparable ages.
These biological differences have important pharmacological implications: the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) demonstrated that Black adults with hypertension had significantly better blood pressure control and fewer cardiovascular events with a thiazide diuretic or calcium channel blocker than with an ACE inhibitor as initial monotherapy — a finding explained by the lower renin profile of Black adults, which makes RAAS blockade with ACE inhibitors less effective as single-agent therapy in this population. Beyond biology, the higher burden of hypertension among Black adults reflects decades of structural inequities: greater exposure to neighborhood-level environmental stressors (violence, noise, pollution), higher rates of food insecurity limiting access to low-sodium, high-potassium diets, greater prevalence of obesity driven by food environment differences, and lower access to primary care and hypertension management. The causes of high blood pressure in Black adults are therefore simultaneously biological and structural, and effective prevention and treatment must address both dimensions.
The Interplay Between Causes: Why Individual Risk Is Cumulative
One of the most important clinical insights into the common causes of high blood pressure is that they do not act independently but rather interact multiplicatively to determine individual blood pressure risk. A person who is genetically predisposed to salt sensitivity, consumes excess sodium, has untreated obstructive sleep apnea, and is significantly overweight does not simply add together the risk contributions of each factor — they experience the amplified, synergistic effect of multiple converging mechanisms all simultaneously promoting sodium retention, sympathetic activation, RAAS upregulation, and reduced nitric oxide bioavailability. This is why blood pressure is so difficult to control with a single medication in patients with multiple contributing causes, and why comprehensive lifestyle modification addressing several causes simultaneously can produce blood pressure reductions that no single drug can match in appropriately selected patients.
The converse is equally important: effectively addressing even one or two of the major contributing causes can produce clinically significant blood pressure improvements even in the presence of other unaddressed risk factors. Treating obstructive sleep apnea in a patient with obesity and high sodium intake may reduce systolic blood pressure by 5–8 mmHg, improving overall control even without changes in diet or weight. Reducing dietary sodium substantially may allow downward medication titration in a patient who cannot currently exercise due to orthopedic limitations. Understanding which common causes of high blood pressure are present and which are most amenable to modification in a specific individual allows a targeted, evidence-based treatment strategy that addresses the root causes of the elevated blood pressure rather than simply adding antihypertensive agents to an undertreated multifactorial condition.
Sugar, Fructose, and Blood Pressure: An Underappreciated Dietary Cause
Beyond sodium, the high sugar content of modern Western diets — particularly high fructose intake from sugar-sweetened beverages, processed snacks, and added sugars in packaged foods — has emerged as a significant and underappreciated dietary contributor to elevated blood pressure. The mechanism is distinct from the sodium-volume pathway and involves fructose’s unique metabolic effects in the liver and kidney. Fructose is metabolized rapidly in hepatocytes through a pathway that generates uric acid as a byproduct — and elevated uric acid inhibits endothelial nitric oxide synthase and increases oxidative stress in vascular endothelial cells, contributing to the endothelial dysfunction and vasoconstriction that raise blood pressure. High fructose consumption has also been shown in experimental models to activate the renin-angiotensin-aldosterone system directly through renal effects, independently of the sodium pathway. Epidemiological studies consistently find that consumption of sugar-sweetened beverages is associated with higher blood pressure and greater incidence of hypertension even after adjusting for total caloric intake and body weight, suggesting mechanisms beyond simple caloric-driven weight gain. Randomized clinical trials of dietary sugar reduction have shown modest but significant blood pressure reductions, adding dietary sugar alongside sodium as a meaningful target for dietary modification in hypertension prevention and management.
Environmental and Occupational Exposures as Causes of Hypertension
The built and natural environment contributes to blood pressure through multiple pathways that are increasingly recognized as significant contributors to population-level hypertension burden. Chronic noise exposure — particularly road traffic noise and aircraft noise — activates the stress response through the hypothalamic-pituitary-adrenal axis and sympathetic nervous system, with studies finding that each 10-decibel increase in nighttime noise exposure is associated with approximately 2 mmHg higher systolic blood pressure. This effect is particularly pronounced during sleep, when the stress response to noise can elevate nocturnal blood pressure even without awakening the individual. Air pollution — specifically fine particulate matter (PM2.5) — is a well-established cardiovascular risk factor that raises blood pressure through multiple mechanisms: systemic inflammation, oxidative stress, endothelial dysfunction, and autonomic nervous system dysregulation. Both short-term (hourly to daily) and long-term (annual average) PM2.5 exposure are associated with higher blood pressure in population studies, and living in areas with higher traffic-related air pollution is an independent predictor of hypertension risk. Lead exposure — historically significant from leaded gasoline and paint — continues to contribute to elevated blood pressure in adults with elevated blood lead levels, through mechanisms including oxidative stress, RAAS activation, and direct renal toxicity. These environmental causes of high blood pressure are not modifiable at the individual level in the way that diet and exercise are, but they are important for public health policy and for understanding why hypertension rates are higher in communities near highways, industrial facilities, and other pollution sources despite similar individual behavioral patterns.